BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20442223)

  • 1. Nicotinic acid decreases apolipoprotein B100-containing lipoprotein levels by reducing hepatic very low density lipoprotein secretion through a possible diacylglycerol acyltransferase 2 inhibition in obese dogs.
    Le Bloc'h J; Leray V; Chetiveaux M; Freuchet B; Magot T; Krempf M; Nguyen P; Ouguerram K
    J Pharmacol Exp Ther; 2010 Aug; 334(2):583-9. PubMed ID: 20442223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of atorvastatin on apolipoprotein B100 containing lipoprotein metabolism in type-2 diabetes.
    Ouguerram K; Magot T; Zaïr Y; Marchini JS; Charbonnel B; Laouenan H; Krempf M
    J Pharmacol Exp Ther; 2003 Jul; 306(1):332-7. PubMed ID: 12684543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on apolipoprotein B100 metabolism in humans.
    Millar JS; Brousseau ME; Diffenderfer MR; Barrett PH; Welty FK; Faruqi A; Wolfe ML; Nartsupha C; Digenio AG; Mancuso JP; Dolnikowski GG; Schaefer EJ; Rader DJ
    Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1350-6. PubMed ID: 16574893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of cholesterol ester of apolipoprotein B100-containing lipoproteins in dogs: evidence for disregarding cholesterol ester transfer.
    Bailhache E; Briand F; Nguyen P; Krempf M; Magot T; Ouguerram K
    Eur J Clin Invest; 2004 Aug; 34(8):527-34. PubMed ID: 15305886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hyperenergetic-fed obese dog, a model of disturbance of apolipoprotein B-100 metabolism associated with insulin resistance: kinetic study using stable isotopes.
    Briand F; Bailhache E; Andre A; Magot T; Krempf M; Nguyen P; Ouguerram K
    Metabolism; 2008 Jul; 57(7):966-72. PubMed ID: 18555839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of short- and long-term growth hormone replacement on lipoprotein composition and on very-low-density lipoprotein and low-density lipoprotein apolipoprotein B100 kinetics in growth hormone-deficient hypopituitary subjects.
    Kearney T; de Gallegos CN; Proudler A; Parker K; Anayaoku V; Bannister P; Venkatesan S; Johnston DG
    Metabolism; 2003 Jan; 52(1):50-9. PubMed ID: 12524662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotinic acid (niacin) receptor agonists: will they be useful therapeutic agents?
    Kamanna VS; Kashyap ML
    Am J Cardiol; 2007 Dec; 100(11 A):S53-61. PubMed ID: 18047854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of obesity on the metabolism of apolipoprotein B in humans.
    Egusa G; Beltz WF; Grundy SM; Howard BV
    J Clin Invest; 1985 Aug; 76(2):596-603. PubMed ID: 4031064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
    Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma markers of cholesterol homeostasis and apolipoprotein B-100 kinetics in the metabolic syndrome.
    Chan DC; Watts GF; Barrett PH; O'Neill FH; Thompson GR
    Obes Res; 2003 Apr; 11(4):591-6. PubMed ID: 12690090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of high plasma triglyceride levels associated with obesity and regional adipose tissue distribution to plasma lipoprotein-lipid composition in premenopausal women.
    Després JP; Moorjani S; Tremblay A; Ferland M; Lupien PJ; Nadeau A; Bouchard C
    Clin Invest Med; 1989 Dec; 12(6):374-80. PubMed ID: 2612090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor-alpha directly stimulates the overproduction of hepatic apolipoprotein B100-containing VLDL via impairment of hepatic insulin signaling.
    Qin B; Anderson RA; Adeli K
    Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1120-9. PubMed ID: 18372392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced conversion of triglyceride-rich lipoproteins and increased low-density lipoprotein removal in LPLS447X carriers.
    Nierman MC; Prinsen BH; Rip J; Veldman RJ; Kuivenhoven JA; Kastelein JJ; de Sain-van der Velden MG; Stroes ES
    Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2410-5. PubMed ID: 16195478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ezetimibe on the in vivo kinetics of apoB-48 and apoB-100 in men with primary hypercholesterolemia.
    Tremblay AJ; Lamarche B; Cohn JS; Hogue JC; Couture P
    Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1101-6. PubMed ID: 16528005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
    Artery; 1982; 10(4):266-85. PubMed ID: 7181672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein B-100 kinetics and static plasma indices of triglyceride-rich lipoprotein metabolism in overweight men.
    Chan DC; Watts GF; Ng TW; Uchida Y; Sakai N; Yamashita S; Barrett PH
    Clin Biochem; 2005 Sep; 38(9):806-12. PubMed ID: 15992790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of extended-release niacin on the postprandial metabolism of Lp(a) and ApoB-100-containing lipoproteins in statin-treated men with type 2 diabetes mellitus.
    Ooi EM; Watts GF; Chan DC; Pang J; Tenneti VS; Hamilton SJ; McCormick SP; Marcovina SM; Barrett PH
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2686-93. PubMed ID: 26515419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Mediterranean diet with and without weight loss on apolipoprotein B100 metabolism in men with metabolic syndrome.
    Richard C; Couture P; Ooi EM; Tremblay AJ; Desroches S; Charest A; Lichtenstein AH; Lamarche B
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):433-8. PubMed ID: 24265415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of growth hormone and/or testosterone on very low density lipoprotein apolipoprotein B100 kinetics and plasma lipids in healthy elderly men: a randomised controlled trial.
    Giannoulis MG; Jackson N; Shojaee-Moradie F; Sonksen PH; Martin FC; Umpleby AM
    Growth Horm IGF Res; 2006; 16(5-6):308-17. PubMed ID: 17029996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effect of fenofibrate and atorvastatin on in vivo kinetics of apolipoproteins B-100 and B-48 in subjects with type 2 diabetes mellitus with marked hypertriglyceridemia.
    Hogue JC; Lamarche B; Deshaies Y; Tremblay AJ; Bergeron J; Gagné C; Couture P
    Metabolism; 2008 Feb; 57(2):246-54. PubMed ID: 18191056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.